Endosome-lysosomes, ubiquitin and neurodegeneration

Advances in Experimental Medicine and Biology

Volumn 389, Issue , 1996, Pages 261-269

  Mayer, R John ^b   Tipler, Carron ^b   Arnold, Jane ^b   Laszlo, Lajos ^b   Al Khedhairy, Abdulaziz ^b   Lowe, James ^a   Landon, Michael ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; OVIS ARIES;

MEMBRANE PROTEIN; UBIQUITIN; NERVE PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; ELECTRON MICROSCOPY; ENDOSOME; IMMUNOCYTOCHEMISTRY; LEWY BODY; LYSOSOME; NERVE DEGENERATION; PRIORITY JOURNAL; SHEEP DISEASE; ANIMAL; BIOREACTOR; DISEASE TRANSMISSION; HUMAN; METABOLISM; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRION DISEASE; REVIEW;

ANIMALS; BIOREACTORS; ENDOSOMES; HUMANS; LYSOSOMES; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NERVOUS SYSTEM DISEASES; PRION DISEASES; UBIQUITINS;

EID: 0030345833     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0335-0_33     Document Type: Article

References (36)

1. Arnold JE, Tipler C, Laszlo L, Hope J, Landon M, Mayer RJ. The abnormal form of the prion protein accumulates in endosome/lysosome-like organelles in scrapie-infected mouse brain. J. Pathol. 1995; In press.
2. Benowitz LI, Rodriguez W, Paskevich P, Mufson EJ, Schenk D, Neve RL. The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects. Exp. Neurol. 1989;106:237-250.
3. Borchelt DR, Taraboulos A, Prusiner SB. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem. 1992;267:16188-16199.
4. Bueler H, Aguzzi A, Sailer A, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993;73:1339-1347.
5. Bueler H, Fischer M, Lang Y, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992;356:577-582.
6. Byrne EJ, Lennox GG, Godwin-Austen RB, et al. Dementia associated with cortical Lewy bodies: proposed clinical diagnostic criteria. Dementia 1991;2:283-284.
7. Cataldo AM, Paskevich PA, Kominami E, Nixon RA. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 1991;88:10998-11002.
8. Cenciarelli C, Hou D, Hsu KC, et al. Activation-induced ubiquitination of the T-cell antigen receptor. Science 1992;257:795-797.
9. Collinge J, Owen F, Poulter M, et al. Prion dementia without characteristic pathology. Lancet 1990;336:7-9.
10. Corder E H , Saunders A M , Strittmatter, W.J., et. al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 1993;261:921-923
11. DeArmond SJ. Alzheimer's disease and Creutzfeldt-Jakob disease: overlap of pathogenic mechanisms. Current Opinion in Neurology 1993;6:872-881.
12. Dickson DW, Wertkin A, Kress Y, Ksiezak-Reding H, Yen S-H. Ubiquitin immunoreactive structures in normal human brains. Lab. Invest. 1990;63:87-99.
13. Esch FS, Keim PS, Beattie EC, et al. Cleavage of amyloid b-peptide during constitutive processing of its precursor. Science 1990;248:1122-1124.
14. Gropper R, Brandt RA, Elias S, et al. The ubiquitin-activating enzyme, El, is required for stress-induced lysosomal degradation of cellular proteins. J. Biol. Chem. 1991;266:3602-3610.
15. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 1992;357:500-503.
16. Jarrett JT, Berger EP, Lansbury PT. The carboxy terminus of the beta-amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993;32:4693-4697.
17. Jensen T G, Roses A D and Jorgensen A L. Apolipoprotein E uptake and degradation via chloroquine-sensitive pathway in cultivated monkey cells overexpressing low density lipoprotein receptor. Neurosci. Lett. 1994;180:193-196
18. Kwak S , Masaki T , Ishiura S. and Sugita H. Multicatalytic proteinase is present in Lewy bodies in neurofibrillary tangles in diffuse Lewy body disease brains. Neurosci. Lett. 1991;128:21-24
19. Laszlo L, Lowe J, Self T, et al. Lysosomes are key organelles in the pathogensis of prion encephalopathies. J. Pathol. 1992;166:333-341.
20. Laszlo L, Tuckwell J, Self T, et al. The latent membrane protein-1 in Epstein-Barr virus-transformed lymphoblastoid cells is found with ubiquitin-protein conjugates and heat-shock protein-70 in lysosomes oriented around the microtubule organizing centre. J. Pathol. 1991;164:203-214.
21. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J. Neurol. Neurosurg. Psychiatr. 1989a;52:1236-1247.
22. Lennox G, Lowe J, Morrell K, Landon M, Mayer RJ. Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J.Neurol.Neurosurg.Psychiatr. 1989b;52:67-71.
23. Low P, Doherty FJ, Sass M, Kovacs J, Mayer RJ, Laszlo L. Immunogold localisation of ubiquitin-protein conjugates in Sf9 insect cells: implications for the biogenesis of lysosome-related organelles. FEBS Lett. 1993;316:152-156.
24. Lowe J, Mayer RJ, Landon M. Ubiquitin in neurodegenerative diseases. Brain Pathol. 1993;3:55-65.
25. Lowe J, Fergusson J, Kenward N, et al. Immunoreactivity to ubiquitin-protein conjugates is present early in the disease process in the brains of scrapie-infected mice. J. Pathol. 1992;168:169-177.
26. Lowe J, Mayer RJ. Ubiquitin, cell stress and diseases of the nervous system. Neuropathol. Appl. Neurobiol. 1990;16:281-291.
27. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer b- protein into filaments. Nature 1994;372:92-94
28. Mayer RJ, Landon M, Laszlo L, Lennox G, Lowe J. Protein processing in lysosomes - the new therapeutic target in neurodegenerative disease. Lancet 1992;340:156-159.
29. Mayer RJ, Arnold J, Laszlo L, Landon M, Lowe J. Ubiquitin in health and disease. Biochim. Biophys. Acta 1991;1089:141-157.
30. McKinley MP, Taraboulos A, Kenaga L, et al. Ultrastructural localisation of scrapie prions in cytoplasmic vesicles of infected cultured cells. Lab. Invest. 1991;65:622-630.
31. Namba Y, Tomonaga M , Kawasaki H , Otomo E and Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and Kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 1991;541:163-166
32. Prusiner SB. Chemistry and biology of prions. Biochemistiy 1992;31:12277-12288.
33. Prusiner SB. Molecular biology of prion diseases. Science 1991;252:1515-1522.
34. Seubert P, Oltersdorf T, Lee MG, et al. Secretion of b-amyloid precursor protein cleaved at the amino terminus of the b-amyloid peptide. Nature 1993;361:260-263.
35. Shyng S -L , Heuser J E and Harris D A. A glycolipid-anchored prion protein is endocytosed via clathrin coated pits. J. Cell Biol. 1994;125:1239-1250
36. Siman R, Mistretta S, Durkin JT, et al. Processing of the b-amyloid precursor. J. Biol. Chem. 1993;268:16602-16609.